Most AI medical devices cleared for use were not tested on patient outcomes

Researchers from the University of Toronto report in PLOS Digital Health that among 1,357 AI-based medical devices cleared by the FDA, only three underwent studies assessing whether they improved real-world patient outcomes. The study highlights a large evidence gap in clinical AI, suggesting current regulatory pathways focus on device accuracy and technical validation rather than robust trials demonstrating meaningful health benefits.